Corrigan Financial, Inc. Abbott Laboratories Transaction History

Corrigan Financial, Inc.

$436 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Sep 01, 2023	SELL	$100.78 - $112.29 $1,007 - $1,122	-10 Reduced 0.3%	3,362 $367 Million
Q1 2023 Sep 01, 2023	SELL	$96.86 - $114.01 $23,924 - $28,160	-247 Reduced 6.83%	3,372 $341 Million
Q4 2022 Sep 01, 2023	SELL	$95.06 - $111.52 $6,749 - $7,917	-71 Reduced 1.92%	3,619 $397 Million
Q3 2022 Sep 01, 2023	SELL	$96.76 - $112.03 $2,612 - $3,024	-27 Reduced 0.73%	3,690 $357 Million
Q2 2022 Sep 01, 2023	SELL	$102.07 - $123.37 $101,865 - $123,123	-998 Reduced 21.17%	3,717 $404 Million
Q1 2022 Sep 01, 2023	BUY	$114.02 - $139.04 $114,248 - $139,318	1,002 Added 26.99%	4,715 $558 Million
Q4 2021 Sep 01, 2023	SELL	$115.53 - $141.46 $27,034 - $33,101	-234 Reduced 5.93%	3,713 $523 Million
Q2 2021 Sep 01, 2023	SELL	$105.79 - $124.53 $22,427 - $26,400	-212 Reduced 5.1%	3,947 $458 Million
Q1 2021 Sep 01, 2023	BUY	$108.84 - $128.23 $6,856 - $8,078	63 Added 1.54%	4,159 $498 Million
Q4 2020 Sep 01, 2023	BUY	$105.0 - $114.42 $45,675 - $49,772	435 Added 11.88%	4,096 $448 Million
Q3 2020 Sep 01, 2023	SELL	$91.64 - $111.29 $64,056 - $77,791	-699 Reduced 16.03%	3,661 $398 Million
Q2 2020 Sep 01, 2023	BUY	$76.57 - $98.0 $76 - $98	1 Added 0.02%	4,360 $399 Million
Q1 2020 Sep 01, 2023	SELL	$62.82 - $91.86 $942 - $1,377	-15 Reduced 0.34%	4,359 $344 Million
Q4 2019 Sep 01, 2023	BUY	$78.51 - $87.4 $1,334 - $1,485	17 Added 0.39%	4,374 $380 Million
Q2 2019 Sep 01, 2023	SELL	$72.88 - $85.0 $58,231 - $67,915	-799 Reduced 15.5%	4,357 $366 Million
Q1 2019 Aug 31, 2023	BUY	$66.22 - $80.06 $119,196 - $144,108	1,800 Added 53.64%	5,156 $412 Million
Q4 2018 Aug 31, 2023	BUY	$65.56 - $74.27 $65 - $74	1 Added 0.03%	3,356 $243 Million
Q3 2018 Aug 31, 2023	SELL	$60.81 - $73.36 $13,195 - $15,919	-217 Reduced 6.08%	3,355 $246 Million
Q2 2018 Aug 31, 2023	BUY	$57.57 - $63.54 $57 - $63	1 Added 0.03%	3,572 $218 Million
Q1 2018 Aug 31, 2023	BUY	$56.27 - $63.62 $56 - $63	1 Added 0.03%	3,571 $214 Million
Q4 2017 Aug 31, 2023	SELL	$53.68 - $57.47 $44,232 - $47,355	-824 Reduced 18.75%	3,570 $204 Million
Q3 2017 Aug 31, 2023	BUY	$48.06 - $53.64 $211,175 - $235,694	4,394	4,394 $234 Million

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

Vanguard Group Inc Valley Forge, PA

168M
Shares

$19.9 Billion
0.35% of portfolio
Black Rock Inc. New York, NY

131M
Shares

$15.6 Billion
0.31% of portfolio
State Street Corp Boston, MA

76.7M
Shares

$9.11 Billion
0.36% of portfolio
Capital International Investors Los Angeles, CA

65.7M
Shares

$7.81 Billion
1.49% of portfolio
Capital Research Global Investors Los Angeles, CA

53.3M
Shares

$6.33 Billion
1.31% of portfolio

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $208B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Corrigan Financial, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Corrigan Financial, Inc. with notifications on news.

Account